Latest News

Feedback sought on Review of the National Medicines Policy September 21, 2021

AusBiotech is seeking member feedback as it responds to the Department of Health’s Review of the National Medicines Policy.

Bionomics expands clinical trial plan for BNC210 September 21, 2021

Clinical-stage biopharmaceutical company Bionomics (ASX:BNO) has announced it will proceed with evaluating its lead clinical compound, BNC210, for the treatment of acute Social Anxiety Disorder.

Certa Therapeutics announces new clinical trial of investigative candidate September 21, 2021

Certa Therapeutics has announced the launch of a Phase 2 trial in Australia for a potential new treatment for Diffuse Systemic Scleroderma.

Researchers identify potential cause and treatment for obesity and insulin resistance September 21, 2021

Monash University researchers have shown for the first time that mesenteric lymphatic dysfunction is a potential cause of and therapeutic target for obesity and insulin resistance.

Another new industry minister as incumbent resigns September 21, 2021

Australia has another new industry minister following the resignation of Christian Porter after just six months in the portfolio.

COVID-19 vaccine patent waiver will not speed up global vaccination say AusBiotech and Medicines September 16, 2021

AusBiotech and Medicines Australia have released a joint statement urging the Australian Government to not support a proposed patent waiver for COVID-19 vaccines and therapies, as it will not help global vaccination.

Chimeric appoints new experts to scientific advisory board September 16, 2021

Clinical-stage cell therapy company Chimeric Therapeutics (ASX:CHM) has announced the appointment of three highly regarded experts to its Cellular Immunotherapy Scientific Advisory Board.

New publication on Radiopharm Theranostics' RAD201 September 16, 2021

Radiopharm Theranostics has announced that its RAD201 breast cancer imaging asset has been the subject of an article published in the peer-reviewed journal Molecular Pharmaceutics.

Australian company's COVID-19 tests approved in Europe September 16, 2021

Australian company Microbio has announced that its COVID-19 tests have been approved for sale and use in Europe.

Emyria expands psychiatry advisory to advance psychedelic-assisted therapies September 16, 2021

Data-backed drug development and care delivery company Emyria (ASX:EMD) has announced the appointment of consultant psychiatrist Dr Jeremy Tannenbaum to its clinical advisory.

$472 million investment in Australia’s health and medical research September 14, 2021

Health minister Greg Hunt has announced over $470 million in new grants for health and medical research.

Joint statement supports Australian Patent Box September 14, 2021

Australia’s health innovators have united to release a statement supporting the introduction of a patent box, and welcoming the important initiative by the federal government.

Most Read

Certa Therapeutics announces new clinical trial of investigative candidate

Bionomics expands clinical trial plan for BNC210

Feedback sought on Review of the National Medicines Policy

Researchers identify potential cause and treatment for obesity and insulin resistance

Another new industry minister as incumbent resigns

New Stories

Feedback sought on Review of the National Medicines Policy

Bionomics expands clinical trial plan for BNC210

Certa Therapeutics announces new clinical trial of investigative candidate

Researchers identify potential cause and treatment for obesity and insulin resistance

Another new industry minister as incumbent resigns

COVID-19 vaccine patent waiver will not speed up global vaccination say AusBiotech and Medicines

Chimeric appoints new experts to scientific advisory board

Sign In

Most Read

Certa Therapeutics announces new clinical trial of investigative candidate

Bionomics expands clinical trial plan for BNC210

Feedback sought on Review of the National Medicines Policy

Researchers identify potential cause and treatment for obesity and insulin resistance

Another new industry minister as incumbent resigns

Follow Us

New Stories

Feedback sought on Review of the National Medicines Policy

Bionomics expands clinical trial plan for BNC210

Certa Therapeutics announces new clinical trial of investigative candidate

Researchers identify potential cause and treatment for obesity and insulin resistance

Another new industry minister as incumbent resigns

COVID-19 vaccine patent waiver will not speed up global vaccination say AusBiotech and Medicines

Chimeric appoints new experts to scientific advisory board